At ADMD, they started commercial operations in the year 2000, specializing in the manufacturing of high quality medical devices. Over the years, they expanded their market share and offerings by introducing a range of standard single use syringes, IV infusion sets and IV Cannula.

In 2003, as part of their contribution to injection safety, they commissioned a new production line dedicated to Auto-Disable (AD) syringes – becoming the first and only manufacturer of AD syringes in the Middle East and Africa. AD syringes virtually eliminate the risk of patient-to-patient infection via blood-borne pathogens (such as Hepatitis B or HIV) because they cannot be refilled and reused. Their syringes enjoy global quality approvals and certifications from bodies such as the ISO and World Health Organization (WHO). They are the only WHO-approved manufacturer of AD syringes in the Middle East, producing over 300 million units per year.

Their key markets include Iraq and the Indian subcontinent, where their products have been helping to deliver the best possible care at the lowest cost possible. Their strong partnership with PAHO and UNICEF has led to new opportunities throughout Latin America and Africa.

Their reputation for quality and safety, endorsed by WHO and Health Ministries worldwide, has led to increased market shares and rapidly expanding production capabilities. Today, their product lines enjoy a growing demand in over 60 countries across the Middle East, Africa, the Indian subcontinent and the Far East.